We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+3.35%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$54.2B
AUM Growth
-$1.5B
Cap. Flow
-$2.46B
Cap. Flow %
-4.53%
Top 10 Hldgs %
9.23%
Holding
3,766
New
402
Increased
1,315
Reduced
1,324
Closed
445

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$549M
2
CVS icon
CVS Health
CVS
+$537M
3
META icon
Meta Platforms (Facebook)
META
+$515M
4
MCD icon
McDonald's
MCD
+$386M
5
HD icon
Home Depot
HD
+$308M

Sector Composition

Rank Sector Weight
1 Healthcare 11.4%
2 Consumer Discretionary 10.14%
3 Technology 10.06%
4 Financials 9.8%
5 Industrials 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BZUN
3226
Baozun
BZUN
$144M
$97K ﹤0.01%
+14,940
New +$92.4K
PFNX
3227
DELISTED
Pfenex Inc.
PFNX
$96K ﹤0.01%
+11,481
New +$92.7K
UNXL
3228
DELISTED
Uni-Pixel, Inc.
UNXL
$95K ﹤0.01%
64,392
-74,185
-54% -$130K
HNR
3229
DELISTED
Harvest Natural Resources
HNR
$95K ﹤0.01%
28,455
-72,573
-72% -$151K
TTOO
3230
DELISTED
T2 Biosystems, Inc
TTOO
$93K ﹤0.01%
2
-3
-60% -$135K
HSTO
3231
DELISTED
Histogen Inc. Common Stock
HSTO
$93K ﹤0.01%
226
+146
+183% +$71.5K
BCIC
3232
BCP Investment Corp
BCIC
$86.9M
$92K ﹤0.01%
2,353
-1,114
-32% -$39.6K
XRM
3233
DELISTED
Xerium Technologies Inc (new)
XRM
$92K ﹤0.01%
14,383
PWE
3234
DELISTED
Penn West Energy Petroleum Ltd
PWE
$92K ﹤0.01%
65,569
+15,700
+31% +$15.6K
ADAP
3235
DELISTED
Adaptimmune Therapeutics
ADAP
$91K ﹤0.01%
11,130
-702
-6% -$6.61K
TVRD
3236
Tvardi Therapeutics
TVRD
$23.5M
$90K ﹤0.01%
521
-157
-23% -$34.2K
SEAC
3237
DELISTED
Seachange International Inc
SEAC
$90K ﹤0.01%
1,407
+3
+0.2% +$221
AVXL icon
3238
Anavex Life Sciences
AVXL
$222M
$88K ﹤0.01%
+14,454
New +$69.8K
YGE
3239
DELISTED
Yingli Green Energy Holding Comp
YGE
$88K ﹤0.01%
21,738
-7,310
-25% -$30.2K
ARIA
3240
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$88K ﹤0.01%
11,943
-1,093,055
-99% -$8.2M
TAT
3241
DELISTED
TransAtlantic Petroleum LTD.
TAT
$88K ﹤0.01%
107,312
MNKD icon
3242
MannKind Corp
MNKD
$1.28B
$87K ﹤0.01%
14,965
-392,012
-96% -$2.42M
GEN
3243
DELISTED
Genesis Healthcare, Inc.
GEN
$84K ﹤0.01%
47,608
-105,189
-69% -$215K
CASC
3244
DELISTED
Cascadian Therapeutics, Inc.
CASC
$83K ﹤0.01%
14,787
-6,539
-31% -$44.4K
JASO
3245
DELISTED
JA Solar Holdings, Co., Ltd
JASO
$79K ﹤0.01%
+11,463
New +$91.1K
FCEL icon
3246
FuelCell Energy
FCEL
$1.7B
$78K ﹤0.01%
+35
New +$80.1K
ONCT
3247
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$76K ﹤0.01%
98
MHGC
3248
DELISTED
Morgans Hotel Group Co.
MHGC
$72K ﹤0.01%
33,696
-9,560
-22% -$18K
STAA icon
3249
STAAR Surgical
STAA
$1.16B
$70K ﹤0.01%
12,625
-46,747
-79% -$302K
CRDF icon
3250
Cardiff Oncology
CRDF
$64.3M
$68K ﹤0.01%
+210
New +$72.3K

Similar funds

D.E. Shaw & Co's Q2 2016 Portfolio in Review

As of Q2 2016, D.E. Shaw & Co held 3,766 positions worth $54.2B, down 2.7% from $55.7B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

D.E. Shaw & Co withdrew a net $2.46B in Q2 2016, closing 445 positions and reducing 1,324 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $369M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, D.E. Shaw & Co opened a new position in Liberty Media Corporation Series C Liberty SiriusXM Common Stock worth $198M.

  • D.E. Shaw & Co's largest Q2 2016 buy was Liberty Media Corporation Series C Liberty SiriusXM Common Stock: 8,430,023 shares worth $198M.
  • D.E. Shaw & Co added most to Amazon in Q2 2016, an estimated $549M increase.
  • D.E. Shaw & Co's biggest Q2 2016 reduction was Booking.com, cutting an estimated $475M.
  • D.E. Shaw & Co fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $369M.
  • D.E. Shaw & Co's ten largest holdings make up 9.2% of its $54.2B portfolio in Q2 2016.
  • D.E. Shaw & Co opened 402 new positions and closed 445 in Q2 2016.
  • D.E. Shaw & Co's portfolio value fell 2.7% quarter-over-quarter to $54.2B.

Based on D.E. Shaw & Co's 13F filing for Q2 2016, filed 15 Aug 2016.